pharmaceuticals

Purdue, Sacklers offer $7.4B in settlement
Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.
Pharmacies unable to fill prescriptions after UnitedHealth cyberattack
More Americans can now get insulin for $35
7 of the biggest medical breakthroughs in 2023
Doctors warn about asthma inhaler switch coming in January
Pfizer worker described moments when tornado struck facility
Sanofi cuts price of insulin to $35
More Stories
Walmart agrees to $3.1B opioid lawsuit settlement framework
Pharmacies limiting number of at-home COVID tests you can buy
CEO in $134M fraud case victim of armed home invasion
Child fights for her life with 'most expensive drug in the world'
CEO accused of $134M fraud case to be on home confinement
CEO had legal issues before alleged Medicare fraud case
CEO arrested at home allegedly bought with defrauded funds
How to lower your prescription drug costs
FDA approves remdesivir to treat COVID-19
Unexplained Illness forces Johnson & Johnson to pause COVID-19 vaccine trial
Robitussin, Dimetapp recalled over issue with dosage cups
Free, driverless prescription drug delivery coming to Houston
Show More
Show Fewer
More Stories
Pharmacies unable to fill prescriptions after UnitedHealth cyberattack
More Americans can now get insulin for $35
7 of the biggest medical breakthroughs in 2023
Doctors warn about asthma inhaler switch coming in January
Pfizer worker described moments when tornado struck facility
Sanofi cuts price of insulin to $35
Walmart agrees to $3.1B opioid lawsuit settlement framework
Pharmacies limiting number of at-home COVID tests you can buy
CEO in $134M fraud case victim of armed home invasion
Child fights for her life with 'most expensive drug in the world'
CEO accused of $134M fraud case to be on home confinement
CEO had legal issues before alleged Medicare fraud case
CEO arrested at home allegedly bought with defrauded funds
How to lower your prescription drug costs
FDA approves remdesivir to treat COVID-19
Unexplained Illness forces Johnson & Johnson to pause COVID-19 vaccine trial
Robitussin, Dimetapp recalled over issue with dosage cups
Free, driverless prescription drug delivery coming to Houston
Show More
Show Fewer